There is still no cure or effective vaccine for HIV, but scientists have opened up new possibilities in HIV treatment and ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients' quality of life over time. It causes neuropsychiatric disorders and ...

The company, in partnership with community leaders and advocates, is dedicated to helping raise awareness about the negative effects of HIV-related stigma as a major barrier to HIV testing ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients’ quality of life over time. It causes neuropsychiatric disorders and ...

Alcohol consumption intensified links between pain and negative affect in HIV-positive patients and those who underwent TKA.

The Trump administration's cuts to foreign aid have resulted in children in Ugandan orphanages losing access to medication, ...

In the first hour of "Connections" on June 13, 2025, guest host Racquel Stephen hosts a discussion on how federal funding ...

(ACS Pharmacol. Transl. Sci. 2024, 7, 8, 2379-2390) Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients’ quality of life ...